PHARMACY INVESTMENT COMPANY
0475.712.645 · rovalta.com · 27/09/2026
VOLUNTARY DISSOLUTION - LIQUIDATION
PHARMACY INVESTMENT COMPANY
Company — Voluntary dissolution - liquidation.
Financial year 2019 · Closed on 31/12/2019
Net result-1,6 k €+5,6 %over 1 year
Gross margin-1,6 k €+4,7 %over 1 year
Equity-50,3 k €-3,3 %over 1 year
Overview
Identity
Source · BCE/KBOPHARMACY INVESTMENT COMPANY is a Private company with limited liability incorporated in 2001. Its registered office is in Charleroi.
- Legal situation
- Voluntary dissolution - liquidation
- BCE/KBO no. / VAT
- BE 0475.712.645
- Incorporation
- 26/09/2001
- Legal form
- Private company with limited liability
- Registered office
- Rue Jean Jaurès 180
6061 Charleroi · WallonieSee on map - Latest accounts
- 31/12/2019
Joint committees (1)
- 313
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2019 | 2018 | 2017 | 2016 | 2015 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -1,6 k € | +4.7% | -1,7 k € | +27.5% | -2,3 k € | +50.4% | -4,7 k € | +21.8% | -6 k € |
| EBITDA | -1,6 k € | +4.7% | -1,7 k € | +27.5% | -2,3 k € | +50.4% | -4,7 k € | +40.0% | -7,8 k € |
| Operating result | -1,6 k € | +4.7% | -1,7 k € | +27.5% | -2,3 k € | +50.4% | -4,7 k € | +40.0% | -7,8 k € |
| Net result | -1,6 k € | +5.6% | -1,7 k € | +26.8% | -2,3 k € | +50.4% | -4,7 k € | +40.6% | -7,9 k € |
| Balance sheet | |||||||||
| Equity | -50,3 k € | -3.3% | -48,7 k € | -3.6% | -47 k € | -5.2% | -44,7 k € | -11.7% | -40,1 k € |
| Total assets | 139,9 k € | -1.1% | 141,5 k € | -1.5% | 143,7 k € | -1.5% | 145,8 k € | +105% | 71,2 k € |
| Cash | 17,9 € | – | 17 € | – | – | ||||
| Debts | 190,2 k € | 0.0% | 190,2 k € | -0.3% | 190,7 k € | +0.1% | 190,6 k € | +71.3% | 111,2 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20191 active · 7 ended
Active mandates
Alain STYNS
ActiveEnded mandates
Other companies at this address
Rue Jean Jaurès 180 6061 Charleroi| Company | CBE no. |
|---|---|
PHARMACIE SAINT CHARLES● Bankrupt | 0475.712.744 |
Financials
Full financial information
Source · NBB| 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2019 | 01/01/2018 | 01/01/2017 | 01/01/2016 | 01/01/2015 | 01/01/2014 |
| Closing of the financial year | 31/12/2019 | 31/12/2018 | 31/12/2017 | 31/12/2016 | 31/12/2015 | 31/12/2014 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/10/2020 | 31/08/2019 | 31/07/2018 | 31/08/2017 | 31/08/2016 | 31/08/2015 |
| General meeting | 14/08/2020 | 15/05/2019 | 16/05/2018 | 17/05/2017 | 18/05/2016 | 20/05/2015 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2019 | 14/08/2020 | 30/10/2020 | French | |
| Micro model | 31/12/2018 | 15/05/2019 | 31/08/2019 | French | |
| Micro model | 31/12/2017 | 16/05/2018 | 31/07/2018 | French | |
| Micro model | 31/12/2016 | 17/05/2017 | 31/08/2017 | French | |
| Abridged model | 31/12/2015 | 18/05/2016 | 31/08/2016 | French | |
| Abridged model | 31/12/2014 | 20/05/2015 | 31/08/2015 | French | |
| Abridged model | 31/12/2013 | 21/05/2014 | 29/08/2014 | French | |
| Abridged model | 31/12/2012 | 15/05/2013 | 30/08/2013 | French | |
| Abridged model | 31/12/2011 | 16/05/2012 | 28/08/2012 | French | |
| Abridged model | 31/12/2010 | 18/05/2011 | 30/08/2011 | French | |
| Abridged model | 31/12/2009 | 19/05/2010 | 29/10/2010 | French | |
| Abridged model | 31/12/2008 | 20/05/2009 | 28/08/2009 | French | |
| Abridged model | 31/12/2007 | 21/05/2008 | 09/07/2008 | French | |
| Abridged model | 31/12/2006 | 16/05/2007 | 25/05/2007 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20191 active · 7 ended
Active mandates
Alain STYNS
ActiveEnded mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2019Annual accounts 2019-1,6 k €↑
- 2018Annual accounts 2018-1,7 k €↑
- 2017Annual accounts 2017-2,3 k €↑
- 2016Annual accounts 2016-4,7 k €↑
- 2015Annual accounts 2015-7,9 k €↓
- 2014Annual accounts 2014-3,7 k €↓
- 2013Annual accounts 2013235,9 k €↑
- 2012Annual accounts 2012-51,7 k €↓
- 2011Annual accounts 201111,8 k €↑
- 2010Annual accounts 2010-77,4 k €↓
- 2009Annual accounts 2009-60,5 k €↓
- 2008Annual accounts 2008-38,8 k €↑
- 2007Annual accounts 2007-423 k €↓
- 2006Annual accounts 200620,7 k €
- 26/09/2001IncorporationPrivate company with limited liability